Results 1 to 10 of about 747,509 (280)

Nonsense mutations can increase mRNA levels [PDF]

open access: yesBiology Open
Nonsense mutations can reduce mRNA levels, as premature translation termination may lead to the activation of nonsense-mediated mRNA decay (NMD). To examine how positional context influences these outcomes, we introduced premature translation termination
Precious O. Owuamalam   +2 more
doaj   +4 more sources

Case report: Two unique nonsense mutations in HTRA1-related cerebral small vessel disease in a Chinese population and literature review [PDF]

open access: yesFrontiers in Neurology, 2022
BackgroundHomozygous or compound heterozygous mutations in the high-temperature requirement A serine protease 1 gene (HTRA1) elicits cerebral autosomal recessive arteriopathy with subcortical infarcts and white matter lesions (CARASIL).
Weijie Chen   +5 more
doaj   +2 more sources

Anticodon-engineered tRNAs restore full-length MeCP2 expression and function in Rett syndrome nonsense mutations [PDF]

open access: yesFrontiers in Neurology
BackgroundRett syndrome (RTT) is a severe neurodevelopmental disorder most commonly caused by loss-of-function mutations in the MECP2 gene, including a substantial fraction of nonsense variants.
Elena Fara   +9 more
doaj   +2 more sources

Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations [PDF]

open access: yesNature Communications
Nonsense mutations – the underlying cause of approximately 11% of all genetic diseases – prematurely terminate protein synthesis by mutating a sense codon to a premature stop or termination codon (PTC).
Nikhil Bharti   +10 more
doaj   +2 more sources

A Simple and Affordable Method to Create Nonsense Mutation Clones of p53 for Studying the Premature Termination Codon Readthrough Activity of PTC124

open access: yesBiomedicines, 2023
(1) Background: A premature termination codon (PTC) can be induced by a type of point mutation known as a nonsense mutation, which occurs within the coding region. Approximately 3.8% of human cancer patients have nonsense mutations of p53.
Chia-Chi Chen   +12 more
doaj   +1 more source

Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process.

open access: yesPLoS Biology, 2023
The introduction of premature termination codons (PTCs), as a result of splicing defects, insertions, deletions, or point mutations (also termed nonsense mutations), lead to numerous genetic diseases, ranging from rare neuro-metabolic disorders to ...
Amnon Wittenstein   +6 more
doaj   +1 more source

A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies. [PDF]

open access: yesPLoS ONE, 2018
Nonsense mutations are present in 10% of patients with CF, produce a premature termination codon in CFTR mRNA causing early termination of translation, and lead to lack of CFTR function.
Daniel R McHugh   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy